NC
STDY

Nexthera Capital’s SteadyMed Ltd STDY Stock Holding History

Nexthera Capital’s Portfolio STDY Stock Details STDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-258,918
Closed -$867K – 58
2017
Q3 		$867K Sell
258,918
-101,708
-28% -$541K 0.22% 33
2017
Q2 		$2.27M Buy
360,626
+355,227
+6,579% +$2.42M 0.99% 24
2017
Q1 		$31K Buy
+5,399
New +$18K 0.02% 36

Other funds holding STDY

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Nexthera Capital's STDY Position: Q4 2017 in Review

Nexthera Capital sold out of SteadyMed Ltd (STDY) in Q4 2017, closing a stake of 258,918 shares — an estimated $867K sold.

Nexthera Capital first reported a position in STDY in Q1 2017 and held it in 3 quarters. The position peaked at $2.27M in Q2 2017. 27 funds tracked by Wall St. Rank hold STDY as of Q4 2017.

  • Nexthera Capital reported no remaining SteadyMed Ltd position as of Q4 2017 after selling out during the quarter.
  • Nexthera Capital sold 258,918 SteadyMed Ltd shares in Q4 2017, an estimated $867K.
  • Nexthera Capital first reported a position in SteadyMed Ltd in Q1 2017 and held it in 3 quarters.
  • Nexthera Capital's SteadyMed Ltd position peaked at $2.27M in Q2 2017.
  • 27 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q4 2017.

Based on Nexthera Capital's 13F filing for Q4 2017, filed 14 Feb 2018.